Article: Other News To Note.

o Aegis Therapeutics Inc., of San Diego, expanded its collaboration with Lexington, Ky.-based Intranasal Technology Inc. to apply Aegis' Intravail drug delivery technology to intranasal heparin and beta-interferon. The agreement aims at addressing the need for an easily administered antithrombiotic medication, as well as to extend central nervous system applications. Terms were not disclosed.

o AmpliMed Corp., of Tucson, Ariz., raised $5 million in its Series B round led by Biotech Insight Ventures, of Pebble Beach, Calif. AmpliMed, which develops oncology products, recently began a Phase I/II study to evaluate its Amplimexon (imexon injection) in combination with ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!